생체신장이식 수혜자 및 공여자 평가
Evaluation of the Recipient and Donor in Living Kidney Transplantation
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Kidney transplantation is the treatment of choice for end-stage renal disease. A successful kidney transplant improves the quality of life and reduces the mortality risk of patients, as compared to maintenance dialysis. The number of patients awaiting kidney transplantation has steadily increased, and the gap between allograft supply and demand continues to widen despite initiatives to expand the use of nonstandard deceased-donor allografts. The use of organs from living donors is one strategy to address the need for transplants. A medical, surgical, and psychosocial evaluation is mandatory prior to living kidney donation to ensure that the donor candidate is in good health and has normal kidney function, is not a risk to the recipient with respect to transmission of infections and malignancy, and will not face unacceptable risks after donation.
Abstract
Kidney transplantation is the treatment of choice for end-stage renal disease. A successful kidney transplant improves the quality of life and reduces the mortality risk of patients, as compared to maintenance dialysis. The number of patients awaiting kidney transplantation has steadily increased, and the gap between allograft supply and demand continues to widen despite initiatives to expand the use of nonstandard deceased-donor allografts. The use of organs from living donors is one strategy to address the need for transplants. A medical, surgical, and psychosocial evaluation is mandatory prior to living kidney donation to ensure that the donor candidate is in good health and has normal kidney function, is not a risk to the recipient with respect to transmission of infections and malignancy, and will not face unacceptable risks after donation.
참고문헌 (33)
- 전홍제, "Outcomes of end-stage renal disease patients on the waiting list for deceased donor kidney transplantation: A single-center study", Kidney Research and Clinical Practice, 38(1), pp.116~123 (2019), 대한신장학회[DOI]
- Schnuelle P, "Impact of renal cadaveric transplantation on survival in end-stage renal failure : evidence for reduced mortality risk compared with hemodialysis during long-term follow-up", J Am Soc Nephrol, 9, pp.2135~2141 (1998)
- "Current renal replacement therapy in Korea" (2019)[URL]
- Harrison EM, "Equity of access to kidney transplantation : to what extent should international guidelines differ", Transplantation, 94, pp.669~670 (2012)
- Dobbels F, "Pretransplant predictors of posttransplant adherence and clinical outcome : an evidence base for pretransplant psychosocial screening", Transplantation, 87, pp.1497~1504 (2009)
- Vivas CA, "Renal transplantation in patients 65 years old or older", J Urol, 147, pp.990~993 (1992)
- Chen KJ, "Risk factors for peptic ulcer disease in renal transplant patients--11years of experience from a single center", Clin Nephrol, 62, pp.14~20 (2004)
- Kao LS, "Prophylactic cholecystectomy in transplant patients : a decision analysis", J Gastrointest Surg, 9, pp.965~972 (2005)
- Lentine KL, "Cardiac disease evaluation and management among kidney and liver transplantation candidates : a scientific statement from the American Heart Association and the American College of Cardiology Foundation", J Am Coll Cardiol, 60, pp.434~480 (2012)
- Wang LW, "Cardiac testing for coronary artery disease in potential kidney transplant recipients", Cochrane Database Syst Rev 2011; (2011)
- Hwang JH, "The prognostic significance of preoperative left ventricular diastolic dysfunction and left atrial enlargement on acute coronary syndrome in kidney transplantation", Oncotarget, 8, pp.71154~71163 (2017)
- Rathbone J, "A systematic review of eculizumab for atypical haemolytic uraemic syndrome(aHUS)", BMJ Open, 3, pp.e003573~ (2013)
- Kasiske BL, "The evaluation of renal transplantation candidates : clinical practice guidelines", Am J Transplant, (1 Suppl 2), pp.3~95 (2001)
- Danovitch GM, "Handbook of kidney transplantation" (2005), Lippincott, Williams & Wilkins
- Batabyal P, "Clinical practice guidelines on wait-listing for kidney transplantation : consistent and equitable", Transplantation, 94, pp.703~713 (2012)
- Chapman JR, "Recurrence of cancer after renal transplantation", Transplant Proc, 33, pp.1830~1831 (2001)
- Barrett WL, "Clinical course of malignancies in renal transplant recipients", Cancer, 72, pp.2186~2189 (1993)
- Chapman JR, "Cancer in the transplant recipient", Cold Spring Harb Perspect Med, 3, pp.a015677~ (2013)
- Zwald F, "Recommendations for solid organ transplantation for transplant candidates with a pretransplant diagnosis of cutaneous squamous cell carcinoma, merkel cell carcinoma and melanoma : a consensus opinion from the International Transplant Skin Cancer Collaborative(ITSCC)", Am J Transplant, 16, pp.407~413 (2016)
- Lentine KL, "Summary of Kidney Disease : Improving Global Outcomes(KDIGO)clinical practice guideline on the evaluation and care of living kidney donors", Transplantation, 101, pp.1783~1792 (2017)
- Davis CL, "Evaluation of the living kidney donor : current perspectives", Am J Kidney Dis, 43, pp.508~530 (2004)
- Lentine KL, "KDIGO clinical practice guideline on the evaluation and care of living kidney donors", Transplantation (2017)
- Lentine KL, "Associations of recipient illness history with hypertension and diabetes after living kidney donation", Transplantation, 91, pp.1227~1232 (2011)
- Locke JE, "Obesity increases the risk of end-stage renal disease among living kidney donors", Kidney Int, 91, pp.699~703 (2017)
- Mandelbrot DA, "The medical evaluation of living kidney donors : a survey of US transplant centers", Am J Transplant, 7, pp.2333~2343 (2007)
- Kido R, "Persistent glomerular hematuria in living kidney donors confers a risk of progressive kidney disease in donors after heminephrectomy", Am J Transplant, 10, pp.1597~1604 (2010)
- Inker LA, "Assessment of glomerular filtration rate and end-stage kidney disease risk in living kidney donor candidates : a paradigm for evaluation, selection, and counseling", Adv Chronic Kidney Dis, 25, pp.21~30 (2018)
- Huang N, "Estimated GFR for living kidney donor evaluation", Am J Transplant, 16, pp.171~180 (2016)
- Gaillard F, "Estimated or measured GFR in living kidney donors work-up", Am J Transplant, 16, pp.3024~3032 (2016)
- Levi ME, "Considerations for screening live kidney donors for endemic infections : a viewpoint on the UNOS policy", Am J Transplant, 14, pp.1003~1011 (2014)
- Nalesnik MA, "Donor-transmitted malignancies in organ transplantation : assessment of clinical risk", Am J Transplant, 11, pp.1140~1147 (2011)
- Kirchner VA, "Infection and cancer screening in potential living donors : Best practices to protect the donor and recipient", Curr Transpl Rep, 2, pp.35~43 (2015)
- Zhang S, "Organ transplantation from donors(cadaveric or living)with a history of malignancy : review of the literature", Transplant Rev(Orlando)2014;, 28, pp.169~175